EMA BE-GL: Clarifications / Corrections? [BE/BA News]

posted by Helmut Homepage – Vienna, Austria, 2010-06-22 20:53 (4613 d 02:50 ago) – Posting: # 5551
Views: 36,290

Dear all,

according to rumours at the recent Workshop in Budapest (235 participants!) EMA started an initiative involving the PK-Drafting Group and the Biostatistics Drafting Group of EWP to clarify/correct some open issues of the new BE-GL.
Points under discussion areWe can expect not only SAS-code, but example data-sets in order to validate other software.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,485 posts in 4,710 threads, 1,603 registered users;
10 visitors (0 registered, 10 guests [including 5 identified bots]).
Forum time: 22:43 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5